1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceuticals: Global Group of Eight (G8) Industry Guide

Pharmaceuticals: Global Group of Eight (G8) Industry Guide

  • January 2016
  • -
  • MarketLine
  • -
  • 189 pages

Summary

Table of Contents

Search Inside

Introduction

The G8 Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2019). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

* Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
* Leading company profiles reveal details of key pharmaceuticals market players’ G8 operations and financial performance
* Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
* Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Highlights

The G8 countries contributed $554.1 billion in 2014 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 3.3% between 2010 and 2014. The G8 countries are expected to reach a value of $684.8 billion in 2019, with a CAGR of 4.3% over the 2014-19 period.
Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $303.9 billion in 2014. This was followed by Japan and Germany, with a value of $85.5 and $37.1 billion, respectively.
The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $390.7 billion in 2016, followed by Japan and Germany with expected values of $102.2 and $44.8 billion, respectively.

Your key questions answered

* What was the size of the G8 pharmaceuticals market by value in 2014?
* What will be the size of the G8 pharmaceuticals market in 2019?
* What factors are affecting the strength of competition in the G8 pharmaceuticals market?
* How has the market performed over the last five years?
* Who are the top competitors in the G8 pharmaceuticals market?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.